Inventor · disambiguated record
Ge Zou
Also filed as: ZOU GE
14 granted patents·7 pending applications·67 citations·filing 2016–2024
89Inventor score
Top patents by PatentIndex Score
21 records- 0197US10065963B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2016·Granted Sep 4, 2018·16 cites·14 claims
- 0296US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 0394US10022387B2Aza-heteroaryl compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2017·Granted Jul 17, 2018·15 cites·35 claims
- 0493US9586949B2Aza-heteroaryl compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2016·Granted Mar 7, 2017·14 cites·26 claims
- 0588US10596184B2Aza-heteroaryl compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Mar 24, 2020·6 cites·21 claims
- 0686US11091491B2Heterocyclic compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·4 cites·37 claims
- 0775US11773102B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Oct 3, 2023·0 cites·27 claims
- 0866US2024360126A1Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0965US2024140933A1Oxoindoline compound for the treatment of inflammatory diseases or cancerHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1057US12503471B2Triazatricycle compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 23, 2025·0 cites·15 claims
- 1157US12486273B2Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
- 1257US12421240B2Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 1356US2023295109A1Pyridinone compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1455US2023279001A1Imidazo[1,2-a]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1553US11952363B2Piperazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Apr 9, 2024·0 cites·14 claims
- 1653US2023041743A11,8-naphthyridin-2-one compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1752US11639352B2Benzothiazole compounds for the treatment of autoimmune diseasesHOFFMANN LA ROCHE·Filed 2018·Granted May 2, 2023·0 cites·12 claims
- 1852US11548884B2Cyclic amidine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 1952US2022395496A1Piperidinyl amine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2052US2023002375A1Hydropyrazino[1,2-b]isoquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2149US12157746B2Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Dec 3, 2024·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ge Zou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →